Hyperthermic isolation limb perfusion (HILP) in the management of extremity melanoma and sarcoma with particular reference to the dosage, pharmacokinetics, and toxicity of cisplatin

• Published in: Cancer treatment and research Vol. 62; p. 241
• Main Authors: Fletcher, W S, Woltering, E A, Moseley, H S, Bos, G, Lebredo, L, Brown, D, Small, K
• Format: Journal Article
• Language: English
• Published: United States 1993
• Subjects: Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Bone Neoplasms - drug therapy; Bone Neoplasms - therapy; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Cisplatin - administration & dosage; Cisplatin - adverse effects; Cisplatin - pharmacokinetics; Cisplatin - therapeutic use; Combined Modality Therapy; Dacarbazine - administration & dosage; Dactinomycin - administration & dosage; Evaluation Studies as Topic; Extremities; Humans; Hyperthermia, Induced; Incidence; Melanoma - drug therapy; Melanoma - therapy; Melphalan - administration & dosage; Neoplasm Metastasis; Osteosarcoma - drug therapy; Osteosarcoma - therapy; Rhabdomyolysis - chemically induced; Skin Neoplasms - drug therapy; Skin Neoplasms - therapy; Treatment Outcome
• ISSN: 0927-3042
• DOI: 10.1007/978-1-4615-3518-8_28